Page last updated: 2024-11-03

procaine and Scleroderma, Systemic

procaine has been researched along with Scleroderma, Systemic in 8 studies

Procaine: A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016).
procaine : A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol.

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BENNEE, J1
FARRINGTON, J1
NAGY, E1
VEZEKENYI, E1
SZABO, P1
TURNER, JP1
SCHMIDT, FR1
Jablonska, S1
Wiskemann, A1
Korff, F1

Other Studies

8 other studies available for procaine and Scleroderma, Systemic

ArticleYear
Scleroderma treated with 2% procaine intravenously.
    Canadian Medical Association journal, 1954, Volume: 70, Issue:1

    Topics: Basidiomycota; Humans; Procaine; Scleroderma, Localized; Scleroderma, Systemic

1954
Intravenous procaine in the management of some cutaneous manifestations of collagen diseases.
    Southern medical journal, 1958, Volume: 51, Issue:11

    Topics: Administration, Intravenous; Collagen Diseases; Dermatomyositis; Disease Management; Humans; Procain

1958
[Treatment of childhood morphea with combined antimalarials and novocain].
    Borgyogyaszati es venerologiaia szemle, 1962, Volume: 38

    Topics: Antimalarials; Basidiomycota; Chloroquine; Humans; Procaine; Scleroderma, Localized; Scleroderma, Sy

1962
[Results of intravenous novocaine in the treatment of progressive scleroderma].
    Archiv fur Dermatologie und Syphilis, 1950, Volume: 191

    Topics: Basidiomycota; Humans; Procaine; Scleroderma, Diffuse; Scleroderma, Localized; Scleroderma, Systemic

1950
Treatment of scleroderma with procaine; report of cases.
    Journal of the American Medical Association, 1950, Dec-30, Volume: 144, Issue:18

    Topics: Basidiomycota; Humans; Procaine; Scleroderma, Localized; Scleroderma, Systemic

1950
[Intravenous procaine in sclerodermatherapy].
    Journal des praticiens; revue generale de clinique et de therapeutique, 1951, Mar-22, Volume: 65, Issue:12

    Topics: Basidiomycota; Procaine; Scleroderma, Localized; Scleroderma, Systemic

1951
Measurement of sensory chronaxie as a diagnostic procedure in scleroderma.
    The British journal of dermatology, 1975, Volume: 92, Issue:2

    Topics: Barbiturates; Bis-Trimethylammonium Compounds; Chlorpromazine; Chronaxy; Diagnosis, Differential; El

1975
[The effect of procaine, griseofulvin and chloroquine on skin perfusion in progressive scleroderma].
    Dermatologische Wochenschrift, 1967, Sep-16, Volume: 153, Issue:37

    Topics: Chloroquine; Griseofulvin; Humans; Procaine; Regional Blood Flow; Scleroderma, Systemic; Skin

1967